Investors were unimpressed after both companies lost money while under threat from larger rivals like Cisco.
Under fire, Theranos C.E.O. stifled bad news. At a presentation to employees last month, Elizabeth Holmes displayed a slide saying the company had developed 304 tests using small volumes of blood. Left unsaid: Most of those experiments hadn’t progressed beyond laboratory research, according to an attendee. – The Wall Street Journal
Yahoo will hold its annual shareholder meeting on Thursday. There are no big questions on the ballot since the company avoided a threatened proxy fight in April after agreeing to appoint four directors chosen by the Starboard Value hedge fund to the board. Still, executives and board members are likely to face questions from restive stockholders about Yahoo’s slow progress in selling its core internet business, even as that business continues to deteriorate. Final bids are due in early July, with Verizon and several private equity consortia remaining top contenders. VINDU GOEL